John P. Schmid - 22 Mar 2024 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
22 Mar 2024
Net transactions value
+$99,738
Form type
4
Filing time
25 Mar 2024, 19:10:26 UTC
Previous filing
14 Mar 2024
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSGN Common Stock Purchase $33,133 +9,156 $3.62 9,156 22 Mar 2024 By Schmid Family Trust U/A dated 8-15-17 F1, F2
transaction DSGN Common Stock Purchase $66,606 +17,809 +195% $3.74 26,965 25 Mar 2024 By Schmid Family Trust U/A dated 8-15-17
holding DSGN Common Stock 30,674 22 Mar 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $3.6187, and the range of prices were between $3.43 and $3.72. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F2 The Reporting Person is trustee of the trust.